-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-20
ARCA Cy5 EGFP mRNA (5-moUTP) provides a dual readout for distinguishing cellular delivery from productive translation. Its Cy5 label supports direct tracking, while EGFP expression helps benchmark delivery vehicles, formulation variables, and intracellular trafficking in mammalian cells.
-
URB597: From FAAH Assay to Pain Mechanism
2026-08-20
URB597 and KDS-4103 provide a selective way to interrogate FAAH-dependent anandamide biology. This article translates recent CBD pain research into a compartment-aware assay strategy for endocannabinoid, neuroinflammation, and affective-neuroscience studies.
-
Fluorouracil: From DNA Stress to Tumor Immunity
2026-08-19
Fluorouracil and 5-Fluorouracil are examined here through a mechanistic framework linking thymidylate synthase inhibition, DNA replication stress, and tumor-immune context. The article translates Wnt/β-catenin research into practical decisions for interpreting colon cancer research, breast cancer research, and combination assays.
-
Aprotinin: Protease Control for Better Assays
2026-08-19
Aprotinin, the bovine pancreatic trypsin inhibitor, can function as more than a protease blocker: it is a mechanistic control for separating proteolysis, inflammation, and transcriptional responses. This guide connects A2574 selection and handling with insights from an efficient GRO-seq workflow.
-
CBD, FAAH, and Affective Dimensions of Orofacial Pain
2026-08-18
This 2026 study shows that cannabidiol (CBD) can reduce inflammatory orofacial pain while also improving anxiety-like, depression-like, and cognitive outcomes in mice. Its multilevel design links peripheral FAAH and CB2-related signaling with central CB1, anandamide, and serotonergic mechanisms, providing a useful framework for dissecting sensory and affective pain biology.
-
MHY1485: Interpreting mTOR–Autophagy Experiments
2026-08-18
MHY1485 is an mTOR activator that helps dissect the relationship between mTOR signaling pathway activity and autophagic flux. This guide emphasizes causal assay design, interpretation of LC3-II accumulation, and applications spanning cancer biology, cell survival, and ovarian follicle development research.
-
Ganoderma Polysaccharide Enhances mRNA-LNP Efficacy
2026-08-17
A 2026 Pharmaceutics study identifies Ganoderma lucidum polysaccharide as an adjunct that may improve mRNA-LNP performance by reducing oxidative stress and modulating innate cellular responses. The formulation increased reporter protein expression in vitro and in vivo, while its translational relevance depends on further optimization, mechanistic validation, and testing across mRNA cargos and delivery contexts.
-
Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels
2026-08-17
Huang and colleagues evaluated sulfamonomethoxine toxicity across algae, cladocerans, and medaka to compare acute and chronic sensitivity at multiple aquatic trophic levels. Their results identify microalgae as particularly sensitive test organisms and show why antibiotic residues from aquaculture require species-specific ecological assessment rather than reliance on a single indicator species.
-
PR-619: Practical DUB Inhibition Workflows
2026-08-16
PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for mapping ubiquitinated-protein accumulation without directly blocking proteasomal catalytic activity. This guide translates its chemistry into reproducible workflows for ubiquitination pathway research, autophagy assays, cancer biology, and neurodegenerative disease models.
-
Clodronate Liposomes for Macrophage Studies
2026-08-15
Clodronate Liposomes provide a route-flexible way to test whether macrophages drive a phenotype in vivo, rather than merely correlating with it. This guide combines depletion controls, tissue-specific verification, and aging-focused phagocytosis assays to improve mechanistic interpretation and reproducibility.
-
FLAG tag Peptide: From Tag to Assay Logic
2026-08-14
The FLAG tag Peptide (DYKDDDDK) enables selective recombinant protein detection and gentle affinity purification. This article connects its assay chemistry to recent Smg5–Hnrnpl–Mag findings and shows how to design protein-level experiments that do not confuse transcript abundance with molecular function.
-
Cy5.5 NHS Ester: Labeling for In Vivo Imaging
2026-08-14
Cy5.5 NHS ester converts amino-bearing proteins, peptides, oligonucleotides, and delivery materials into trackable near-infrared probes. This practical guide connects amine-labeling chemistry with nanoparticle and hydrogel studies, emphasizing formulation control, purification, imaging controls, and troubleshooting for reproducible in vivo fluorescence imaging.
-
URB597 (KDS-4103) Workflow for FAAH Studies
2026-08-13
URB597 enables direct, selective FAAH inhibition for separating anandamide biology from broader cannabinoid-drug effects. This practical workflow connects target engagement, pain-related behavior, LC-MS/MS, and neuroinflammation readouts for more interpretable endocannabinoid experiments.
-
Taltirelin Acetate: From Receptor to Readout
2026-08-13
Taltirelin acetate links selective TRH receptor pharmacology with sustained motor and neuroprotective readouts. This guide interprets the key OSA study and translates its findings into better assay design across neuroscience, Parkinson’s disease, itch, and formulation research.
-
Targeted mRNA Delivery to Islet β Cells
2026-08-12
Enriquez and colleagues developed eGLP-1-conjugated lipid nanoparticles that enrich mRNA delivery to pancreatic β cells and demonstrated functional delivery in mouse, human, and xenotransplant models. Delivery of PD-L1 mRNA reduced insulitis and delayed autoimmune diabetes in NOD mice, while the platform also highlights the remaining translational and targeting limitations of β cell-directed RNA therapeutics.